The 3 Worst-Performing Big Pharma Stocks of 2013: LLY, NVO, SNY

Before you go, we thought you'd like these...
Before you go close icon

The S&P 500 soared more than 32% in 2013, and several big pharma companies also soared. Some, however -- namely Sanofi Novo Nordisk , and Eli Lilly  -- significantly trailed their peers. To find out why these stocks stumbled last year, and what they need to do to soar this year, click on the following slideshow.

Top stock pick for 2014
There's a huge difference between a good stock, and a stock that can make you rich. The Motley Fool's chief investment officer has selected his No. 1 stock for 2014, and it's one of those stocks that could make you rich. You can find out which stock it is in the special free report: "The Motley Fool's Top Stock for 2014." Just click here to access the report and find out the name of this under-the-radar company.

The article The 3 Worst-Performing Big Pharma Stocks of 2013: LLY, NVO, SNY originally appeared on

Max Macaluso, Ph.D., and The Motley Fool have no position in any of the stocks mentioned. Try any of our Foolish newsletter services free for 30 days. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 - 2014 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Read Full Story

Sign up for Finance Report by AOL and get everything from business news to personal finance tips delivered directly to your inbox daily!

Subscribe to our other newsletters

Emails may offer personalized content or ads. Learn more. You may unsubscribe any time.

People are Reading